3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one

C98H89F6N17O12S2 — CID 159445462

IUPAC3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one
SMILESCN(C)CCN(C)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1.CN1CCN(c2ccc3cc(-c4nc(C(F)(F)F)cs4)c(=O)oc3c2)CC1.Cc1ccc2nc(-c3cc4ccc(N5CCNCC5)cc4oc3=O)cn2c1.O=c1oc2cc(N3CCNCC3)ccc2cc1-c1nc(C(F)(F)F)cs1.O=c1oc2cc(N3CCNCC3)ccc2cc1-c1noc(-c2ccccc2)n1
InChIInChI=1S/C21H18N4O3.C21H20N4O2.C21H21N3O3.C18H16F3N3O2S.C17H14F3N3O2S/c26-21-17(19-23-20(28-24-19)14-4-2-1-3-5-14)12-15-6-7-16(13-18(15)27-21)25-10-8-22-9-11-25;1-14-2-5-20-23-18(13-25(20)12-14)17-10-15-3-4-16(11-19(15)27-21(17)26)24-8-6-22-7-9-24;1-23(2)10-11-24(3)15-9-8-14-12-16(21(25)27-19(14)13-15)20-22-17-6-4-5-7-18(17)26-20;1-23-4-6-24(7-5-23)12-3-2-11-8-13(17(25)26-14(11)9-12)16-22-15(10-27-16)18(19,20)21;18-17(19,20)14-9-26-15(22-14)12-7-10-1-2-11(8-13(10)25-16(12)24)23-5-3-21-4-6-23/h1-7,12-13,22H,8-11H2;2-5,10-13,22H,6-9H2,1H3;4-9,12-13H,10-11H2,1-3H3;2-3,8-10H,4-7H2,1H3;1-2,7-9,21H,3-6H2
InChIKeyLSRZOPRKQLXNBF-UHFFFAOYSA-N
MW1875.02 g/mol
LogP16.38
Rot. Bonds14

About 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one

3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one (PubChem CID 159445462) has the molecular formula C98H89F6N17O12S2 and a molecular weight of 1875.02 g/mol. Its IUPAC name is 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one.

Molecular Properties

Compound Name3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one
PubChem CID159445462
Molecular FormulaC98H89F6N17O12S2
Molecular Weight1875.02 g/mol
Exact Mass1873.62
IUPAC Name3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one
SMILESCN(C)CCN(C)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1.CN1CCN(c2ccc3cc(-c4nc(C(F)(F)F)cs4)c(=O)oc3c2)CC1.Cc1ccc2nc(-c3cc4ccc(N5CCNCC5)cc4oc3=O)cn2c1.O=c1oc2cc(N3CCNCC3)ccc2cc1-c1nc(C(F)(F)F)cs1.O=c1oc2cc(N3CCNCC3)ccc2cc1-c1noc(-c2ccccc2)n1
InChIInChI=1S/C21H18N4O3.C21H20N4O2.C21H21N3O3.C18H16F3N3O2S.C17H14F3N3O2S/c26-21-17(19-23-20(28-24-19)14-4-2-1-3-5-14)12-15-6-7-16(13-18(15)27-21)25-10-8-22-9-11-25;1-14-2-5-20-23-18(13-25(20)12-14)17-10-15-3-4-16(11-19(15)27-21(17)26)24-8-6-22-7-9-24;1-23(2)10-11-24(3)15-9-8-14-12-16(21(25)27-19(14)13-15)20-22-17-6-4-5-7-18(17)26-20;1-23-4-6-24(7-5-23)12-3-2-11-8-13(17(25)26-14(11)9-12)16-22-15(10-27-16)18(19,20)21;18-17(19,20)14-9-26-15(22-14)12-7-10-1-2-11(8-13(10)25-16(12)24)23-5-3-21-4-6-23/h1-7,12-13,22H,8-11H2;2-5,10-13,22H,6-9H2,1H3;4-9,12-13H,10-11H2,1-3H3;2-3,8-10H,4-7H2,1H3;1-2,7-9,21H,3-6H2
InChIKeyLSRZOPRKQLXNBF-UHFFFAOYSA-N
XLogP16.38
TPSA317.85 Ų
H-Bond Donors3
H-Bond Acceptors31
Rotatable Bonds14
Heavy Atoms135
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001875.02
LogP ≤ 516.38
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1031

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cumarine', 'substructure': 'N/A'}

Analyze 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one?
The IUPAC name of 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one (CID 159445462) is 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one.
What is the SMILES notation for 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one?
The canonical SMILES for 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one is CN(C)CCN(C)c1ccc2cc(-c3nc4ccccc4o3)c(=O)oc2c1.CN1CCN(c2ccc3cc(-c4nc(C(F)(F)F)cs4)c(=O)oc3c2)CC1.Cc1ccc2nc(-c3cc4ccc(N5CCNCC5)cc4oc3=O)cn2c1.O=c1oc2cc(N3CCNCC3)ccc2cc1-c1nc(C(F)(F)F)cs1.O=c1oc2cc(N3CCNCC3)ccc2cc1-c1noc(-c2ccccc2)n1.
What is the InChIKey of 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one?
The InChIKey is LSRZOPRKQLXNBF-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H18N4O3.C21H20N4O2.C21H21N3O3.C18H16F3N3O2S.C17H14F3N3O2S/c26-21-17(19-23-20(28-24-19)14-4-2-1-3-5-14)12-15-6-7-16(13-18(15)27-21)25-10-8-22-9-11-25;1-14-2-5-20-23-18(13-25(20)12-14)17-10-15-3-4-16(11-19(15)27-21(17)26)24-8-6-22-7-9-24;1-23(2)10-11-24(3)15-9-8-14-12-16(21(25)27-19(14)13-15)20-22-17-6-4-5-7-18(17)26-20;1-23-4-6-24(7-5-23)12-3-2-11-8-13(17(25)26-14(11)9-12)16-22-15(10-27-16)18(19,20)21;18-17(19,20)14-9-26-15(22-14)12-7-10-1-2-11(8-13(10)25-16(12)24)23-5-3-21-4-6-23/h1-7,12-13,22H,8-11H2;2-5,10-13,22H,6-9H2,1H3;4-9,12-13H,10-11H2,1-3H3;2-3,8-10H,4-7H2,1H3;1-2,7-9,21H,3-6H2.
What are the key properties of 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one?
3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one has a molecular weight of 1875.02 g/mol, XLogP of 16.38, 14 rotatable bonds, 3 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 3-(1,3-benzoxazol-2-yl)-7-[2-(dimethylamino)ethyl-methylamino]chromen-2-one;3-(6-methylimidazo[1,2-a]pyridin-2-yl)-7-piperazin-1-ylchromen-2-one;7-(4-methylpiperazin-1-yl)-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one;3-(5-phenyl-1,2,4-oxadiazol-3-yl)-7-piperazin-1-ylchromen-2-one;7-piperazin-1-yl-3-[4-(trifluoromethyl)-1,3-thiazol-2-yl]chromen-2-one is sourced from PubChem (CID 159445462), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).